Live feed16:17:00·114dPRReleasevia QuantisnowLilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseasesByQuantisnow·Wall Street's wire, on your screen.LLY· Eli Lilly and CompanyVTYX· Ventyx Biosciences Inc.Health Care